How an Israeli startup redomiciles to a Delaware C-corp

Why flip at all

Most Israeli startups that raise from US investors end up with a Delaware corporation on top. Shareholders swap their Israeli shares for shares of a new Delaware parent, and the Israeli company becomes a wholly owned subsidiary keeping the people and the IP. US investors, acquirers and public markets expect that structure, and flipping gets you there without starting over.

A Delaware parent goes on top, and the Israeli company keeps the people and the IP underneath.

The reasons are practical more than legal. US venture funds are set up to invest in Delaware corporations, and many have limited partnership agreements or tax reasons that make a direct investment in a foreign company awkward. US acquirers pay for a Delaware entity they can merge with under familiar law. A US listing is far simpler for a Delaware issuer. And for investors, only stock issued by a domestic C corporation can ever be qualified small business stock.

A flip costs money, and it isn't always the right call. A company that will sell to a European or Israeli acquirer, or that never raises US institutional money, may be better off staying Israeli. But when a company's customers, capital and exit are in the United States, flipping is the default and the real question is when. Olivent requires portfolio companies to be, or to become, Delaware C corporations before an investment closes.

The share exchange

Mechanically, a flip is a share-for-share exchange. A new Delaware corporation is formed, and every holder of shares, options and other rights swaps their Israeli equity for equivalent equity in it. The Israeli company becomes a subsidiary, its cap table collapses to a single line, and the Delaware cap table mirrors what the Israeli one looked like the day before.

Every holder swaps like for like, so the Delaware cap table mirrors the Israeli one from the day before.

The exchange has to be complete. A shareholder who doesn't participate stays on as a minority holder in the subsidiary, and that breaks the structure. Option plans roll into a new plan at the parent. Israeli employees' options, usually granted under the Israeli tax-favoured "section 102" trustee track, need a matching arrangement so they don't lose that status in the exchange. Existing investor rights, preferred share terms and board composition all get re-documented at the Delaware level.

On the US side, counsel checks the exchange against the anti-inversion and outbound transfer rules that can treat a new foreign-owned US parent unfavourably. They also confirm that the parent's basis in the subsidiary and the shareholders' basis in their new stock are what everyone expects. For investors, stock received in the exchange is treated as issued for property, so it can start a QSBS holding period at the flip.

The Israeli tax ruling

Without a ruling, the exchange is a taxable sale for Israeli shareholders, since they've disposed of their shares. The Israel Tax Authority grants rulings deferring that tax event, and since 2018 it has published a "green route" under which companies formed in or after 2018 can get the deferral within weeks if they meet the published conditions.

The ruling only defers the Israeli tax, and its conditions have to hold for two years after the flip.

You file the application before the flip, and you should assume a pre-ruling takes about three months from filing. The conditions are the real substance of the deal with the tax authority. The intellectual property, including modifications and derivatives developed from it, has to stay in the Israeli company. The flip can't be a way to move the technology offshore. Shareholders who elect the deferral must keep at least a quarter of their shares and rights for at least two years after the flip, and deposit those shares with an Israeli trustee, who is responsible for withholding tax when they're eventually sold. The Delaware parent has to keep owning the Israeli company for at least two years. The parent must be resident in a country with a tax treaty with Israel and can't be a pass-through entity, and the Israeli company can't be primarily a real-estate business.

Keep in mind that a deferral only postpones the tax. The Israeli shareholders' gain crystallises when they sell the Delaware stock, and the trustee withholds. Distributions from the subsidiary to the parent out of pre-flip earnings carry Israeli dividend withholding, typically 25% or 30% depending on the parent's holding, and the parent gets no credit for it in the United States. A company with retained earnings in Israel should plan for that before it flips.

Timeline and cost

A clean flip of a young company takes two to three months from decision to closing, most of it spent waiting on the tax ruling. It costs the company in the low tens of thousands of dollars in Israeli and US legal fees, plus the ongoing cost of running a second entity.

Plan on two to three months, and most of that is waiting on the tax ruling.

Many shareholders, foreign option holders or retained earnings make it slower and more expensive, because every holder has to sign and the ruling has to address each situation. The critical path runs through three things. The ruling application, which should go in as soon as the decision is made. Signatures from every holder, including departed employees with vested options. And re-documenting investor rights at the parent. Investors leading a round into a company that hasn't flipped usually make the flip a closing condition and price the round on the Delaware stock, so the round timetable and the flip timetable become the same timetable.

After closing, the company runs two sets of books and filings: an Israeli subsidiary with its own tax return and a transfer-pricing arrangement for the services it provides to the parent, and the Delaware parent with its US filings. That's the recurring cost of the structure, and it's why very early companies sometimes wait until the first institutional round to flip.

Common mistakes

The costliest mistakes are the ones that break the tax ruling's conditions or the QSBS position after the fact. Moving intellectual property to the parent within the two-year period, diluting the electing shareholders below the required holding, or selling the subsidiary out of the parent inside the window can all unwind the deferral.

Flip early, while the cap table is short, and most of these mistakes never come up.

On the QSBS side, flipping after a large round has already gone into the Israeli entity can push gross assets over the QSBS threshold on the day the Delaware stock is issued. Other problems come up again and again: option holders left out of the exchange, so the plan has to be fixed at the next round; section 102 options rolled over without keeping their trustee status; investor rights at the parent that don't match the Israeli agreements they replaced; and an exit structured as a sale of the subsidiary instead of the parent. That last one triggers two levels of Israeli tax (corporate tax at the subsidiary and dividend tax on the way up) and cuts what the acquirer will pay.

Timing avoids most of this. A company that flips before its first institutional round, while the cap table is short and there are no retained earnings, gets the ruling quickly, issues all its investor stock from Delaware, and never has to reconcile two histories. If you're raising from Olivent, expect the flip to be on the closing checklist. The apply page is the place to start that conversation.